Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marini

Showing results (431-440 of 852) with videos related to

Pageof 86
Sort By:
Journal of Clinical Pharmacology|November 27, 2009
Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjectsZhenhua Xu, Qingmin Wang, Yanli Zhuang, et al.
Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.
Plos One|May 23, 2012
A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfectaMasaki Takagi, Tomohiro Ishii, Aileen M Barnes, et al.
Cancer Research|December 20, 2007
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironmentAnn H Klopp, Erika L Spaeth, Jennifer L Dembinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 8, 2008
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursorsThomas E Uveges, Patricia Collin-Osdoby, Wayne A Cabral, et al.
The AAPS Journal|October 4, 2014
Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
Journal of Proteomics|August 1, 2012
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approachLaura Bianchi, Assunta Gagliardi, Roberta Gioia, et al.
The American Journal of Physiology|December 1, 1990
Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell linesD M Jefferson, J D Valentich, F C Marini, et al.
JBMR Plus|August 14, 2025
Moderately severe osteogenesis imperfecta-like osteochondrodysplasia associated with heterozygous variants in both <i>COL1A2</i> and <i>TRPV4</i>Elena F Evans, Woo Young Chung, Aileen M Barnes, et al.
Bone|June 19, 2013
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaJ A Meganck, D L Begun, J D McElderry, et al.
Pageof 86

Showing results (431-440 of 852) with videos related to

Sort By:
Pageof 86
Journal of Clinical Pharmacology|November 27, 2009
Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjectsZhenhua Xu, Qingmin Wang, Yanli Zhuang, et al.
Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.
Plos One|May 23, 2012
A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfectaMasaki Takagi, Tomohiro Ishii, Aileen M Barnes, et al.
Cancer Research|December 20, 2007
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironmentAnn H Klopp, Erika L Spaeth, Jennifer L Dembinski, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 8, 2008
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursorsThomas E Uveges, Patricia Collin-Osdoby, Wayne A Cabral, et al.
The AAPS Journal|October 4, 2014
Systematic verification of bioanalytical similarity between a biosimilar and a reference biotherapeutic: committee recommendations for the development and validation of a single ligand-binding assay to support pharmacokinetic assessmentsJoseph C Marini, Michael Anderson, Xiao-Yan Cai, et al.
Journal of Proteomics|August 1, 2012
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approachLaura Bianchi, Assunta Gagliardi, Roberta Gioia, et al.
The American Journal of Physiology|December 1, 1990
Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell linesD M Jefferson, J D Valentich, F C Marini, et al.
JBMR Plus|August 14, 2025
Moderately severe osteogenesis imperfecta-like osteochondrodysplasia associated with heterozygous variants in both <i>COL1A2</i> and <i>TRPV4</i>Elena F Evans, Woo Young Chung, Aileen M Barnes, et al.
Bone|June 19, 2013
Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaJ A Meganck, D L Begun, J D McElderry, et al.
Pageof 86